Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 09, 2020

SELL
$9.12 - $17.78 $193,061 - $376,384
-21,169 Closed
0 $0
Q4 2019

Jan 09, 2020

SELL
$16.11 - $25.98 $11,341 - $18,289
-704 Reduced 3.22%
21,169 $341,000
Q3 2019

Oct 30, 2019

SELL
$18.28 - $26.91 $211,298 - $311,052
-11,559 Reduced 34.57%
21,873 $400,000
Q2 2019

Jul 12, 2019

BUY
$17.68 - $21.57 $63,842 - $77,889
3,611 Added 12.11%
33,432 $719,000
Q1 2019

Apr 09, 2019

BUY
$14.41 - $19.64 $136,923 - $186,619
9,502 Added 46.76%
29,821 $585,000
Q3 2018

Oct 09, 2018

SELL
$17.57 - $23.95 $28,059 - $38,248
-1,597 Reduced 7.29%
20,319 $487,000
Q2 2018

Jul 11, 2018

SELL
$11.6 - $19.27 $45,889 - $76,232
-3,956 Reduced 15.29%
21,916 $420,000
Q1 2018

Apr 17, 2018

BUY
$11.77 - $16.08 $304,513 - $416,021
25,872 New
25,872 $320,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.